Related Experiment Video
Updated: Sep 30, 2025

08:22
Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
166
Microglia Modulate Cortical Spreading Depolarizations After Ischemic Stroke: A Narrative Review
Kathryn N Kearns1, Lei Liu1, Sauson Soldozy1
1Department of Neurosurgery, University of Virginia Health System, Charlottesville, VA, USA.
Neurocritical Care
|March 15, 2022
Summary
Cortical spreading depolarizations (CSDs) worsen stroke outcomes by disrupting brain homeostasis. Microglia, brain immune cells, critically influence CSDs, suggesting microglial calcium signaling as a therapeutic target for stroke.
Area of Science:
- Neuroscience
- Neurocritical Care
- Neuroimmunology
Background:
- Cortical spreading depolarizations (CSDs) are waves of suppressed brain activity linked to poor outcomes in conditions like ischemic stroke.
- CSDs cause ionic and metabolic disruptions in the brain's peri-infarct zone, potentially worsening stroke-related tissue damage.
- Microglia, the brain's primary immune cells, are increasingly recognized for their role in CSD initiation and propagation.
Purpose of the Study:
- To review the role of CSDs in ischemic stroke.
- To explore how microglia modulate peri-infarct CSDs (iso-electric depolarizations).
- To discuss microglial calcium signaling as a potential therapeutic target for stroke.
Main Methods:
- Literature review and synthesis of recent studies on CSDs and microglia in ischemic stroke.
- Discussion of the pathophysiological mechanisms linking CSDs, microglia, and stroke outcomes.
- Exploration of microglial calcium dynamics as a therapeutic avenue.
Main Results:
- CSDs are implicated in exacerbating infarction and worsening clinical outcomes following ischemic stroke.
- Microglia play a significant role in the initiation and propagation of CSDs, particularly in the peri-infarct region.
- Microglial calcium signaling represents a promising target for mitigating CSD-associated damage in stroke.
Conclusions:
- CSDs are a significant factor in ischemic stroke pathology, contributing to infarct expansion and poorer outcomes.
- Targeting microglial function, specifically their calcium signaling pathways, may offer a novel therapeutic strategy to reduce CSD-induced brain damage after stroke.

